Published in J Clin Invest on February 01, 1974
Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi. J Exp Med (1979) 5.22
The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med (1977) 4.46
Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria. J Exp Med (1981) 4.08
Synthesis of the second component of complement by long-term primary cultures of human monocytes. J Exp Med (1976) 3.64
Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products. J Exp Med (1975) 3.17
Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates. J Clin Invest (1982) 2.23
Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages. J Exp Med (1975) 1.77
Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology (1979) 1.55
Pathogenesis of fever in delayed hypersensitivity: role of monocytes. Infect Immun (1978) 1.40
Stimulation of polymorphonuclear leukocyte bactericidal activity by supernatants of activated human mononuclear cells. Infect Immun (1978) 1.18
Human erythroid burst-forming units. Growth in vitro is dependent on monocytes, but not T lymphocytes. J Clin Invest (1981) 1.07
Monocytes and macrophages in malignant melanoma. III. Reduction of nitroblue tetrazolium by peripheral blood monocytes. Br J Cancer (1978) 0.94
Characteristics of human monocytes cultured in the Teflon culture bag. Immunology (1982) 0.93
An absolute requirement for serum macromolecules in phytohaemagglutinin-induced human lymphocyte DNA synthesis. Clin Exp Immunol (1975) 0.82
Characterization of monocyte maturation in adherent and suspension cultures and its application to study monocyte differentiation in Hodgkin's disease. Clin Exp Immunol (1983) 0.76
Monocyte activation in horses persistently infected with equine infectious anemia virus. Infect Immun (1975) 0.76
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem (1958) 11.74
Alterations of macrophage functions by mediators from lymphocytes. J Exp Med (1971) 7.95
Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70
Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med (1973) 3.98
An in vitro assay for cellular hypersensitivity in man. J Immunol (1970) 3.73
Activation of normal rabbit macrophage monolayers by supernatants of antigen-stimulated lymphocytes. J Immunol (1970) 3.17
The interaction between human monocytes and red cells. Binding characteristics. J Exp Med (1970) 1.77
Bone marrow precursor cells specify serological properties of antibody. Cell Immunol (1972) 0.92
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
Alterations of macrophage functions by mediators from lymphocytes. J Exp Med (1971) 7.95
Genetic variation of Drosophila melanogaster natural populations. Trends Genet (1988) 4.62
Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis. J Exp Med (1965) 4.62
The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med (1973) 4.51
A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol (1979) 4.17
Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med (1973) 3.98
Leukotactic factor produced by sensitized lymphocytes. Science (1969) 3.95
An in vitro assay for cellular hypersensitivity in man. J Immunol (1970) 3.73
Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy (1972) 3.47
Macrophage migration. Fed Proc (1990) 3.39
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med (1999) 3.23
The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol (1970) 3.17
rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis (1996) 2.93
Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell Immunol (1970) 2.86
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.81
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81
Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med (1978) 2.50
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 2.31
Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1989) 2.24
Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol (2001) 2.20
The compartmentalization of antigen-reactive lymphocytes in desensitized guinea pigs. J Exp Med (1971) 2.18
Metabolic and functonal studies on activated mouse macrophages. J Exp Med (1973) 2.17
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils. J Exp Med (1977) 2.06
Macrophage activation by lymphocyte mediators. Fed Proc (1975) 1.99
Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg (1998) 1.99
Host-plant specialization in the Drosophila melanogaster species complex: a physiological, behavioral, and genetical analysis. Proc Natl Acad Sci U S A (1991) 1.98
Similarities and differences in latitudinal adaptation of two Drosophila sibling species. Nature (1975) 1.96
Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci U S A (1986) 1.93
Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis (2005) 1.91
Evolution in a cosmopolitan species: genetic latitudinal clines in Drosophila melanogaster wild populations. Experientia (1975) 1.91
Immunochemical studies on the specificity of cellular hypersensitivity. The in vitro inhibition of peritoneal exudate cell migration by cehmically defined antigens. J Exp Med (1968) 1.90
Monoclonal antibodies that distinguish between New World species of Leishmania. Nature (1981) 1.89
Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A. J Immunol (1972) 1.82
Mediators produced by sensitized lymphocytes. Fed Proc (1972) 1.79
Mitochondrial DNA variability in Drosophila simulans: quasi absence of polymorphism within each of the three cytoplasmic races. Heredity (Edinb) (1988) 1.76
Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol (2001) 1.74
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll. Exp Parasitol (1982) 1.66
Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies. Am J Trop Med Hyg (1987) 1.65
Prevention of MIF activity by agents known to increase cellular cyclic AMP. J Immunol (1973) 1.64
Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol (1970) 1.64
In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis. Infect Immun (1987) 1.63
Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. Cell Immunol (1972) 1.63
Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc Natl Acad Sci U S A (1981) 1.54
Lymphocyte mediators and cellular hypersensitivity. N Engl J Med (1973) 1.53
Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo. J Exp Med (1984) 1.51
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med (1980) 1.50
Genetics of morphological differences and hybrid sterility between Drosophila sechellia and its relatives. Genet Res (1991) 1.49
The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med (1971) 1.47
Enzymatic and quantitative variation in European and African populations of Drosophila simulans. Heredity (Edinb) (1985) 1.47
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.47
Autoimmunity to collagen in adjuvant arthritis of rats. J Clin Invest (1980) 1.44
Low allozyme and mtDNA variability in the island endemic species Drosophila sechellia (D. melanogaster complex). Experientia (1990) 1.42
Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med (1987) 1.41
In vitro studies of the suppression of delayed hypersensitivity by the induction of partial tolerance. J Exp Med (1970) 1.41
Stress-induced enhancement of skin immune function: A role for gamma interferon. Proc Natl Acad Sci U S A (2000) 1.39
IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophil response to Trichinella spiralis infection. J Exp Med (1981) 1.36
Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun (2001) 1.36
In vitro lymphocyte response of patients with immunologic deficiency diseases. N Engl J Med (1970) 1.34
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med (1979) 1.34
Retracted Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. J Immunol (1991) 1.33
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33
Retracted Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J Immunol (1993) 1.31
Further studies on migration inhibitory factor (MIF): evidence for its glycoprotein nature. J Immunol (1971) 1.30
Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J Immunol (1975) 1.27
Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis. J Immunol (1982) 1.27
Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. N Engl J Med (1975) 1.27
A microsatellite-based multilocus phylogeny of the Drosophila melanogaster species complex. Curr Biol (1998) 1.26
Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s). J Exp Med (1982) 1.25
Comparative analysis of morphological traits among Drosophila melanogaster and D. simulans: genetic variability, clines and phenotypic plasticity. Genetica (2004) 1.23
In vitro demonstration of cellular sensitivity in allergic encephalomyelitis. J Exp Med (1965) 1.22
Competence of the human host as a reservoir for Leishmania chagasi. J Infect Dis (2000) 1.21
Short-range genetic structure of Drosophila melanogaster populations in an Afrotropical urban area and its significance. Proc Natl Acad Sci U S A (1989) 1.21
Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes. J Immunol (1975) 1.19
Biological role of alcohol dehydrogenase in the tolerance of Drosophila melanogaster to aliphatic alochols: utilization of an ADH-null mutant. Biochem Genet (1976) 1.19
Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol Infect (2006) 1.19
In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages. J Immunol (1981) 1.18
IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Eur J Immunol (2000) 1.17
Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med (1981) 1.17
Chill-coma tolerance, a major climatic adaptation among Drosophila species. Evolution (2001) 1.16
Effect of multiparity on human maternal hypersensitivity to foetal antigen. Nature (1973) 1.15
Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. J Immunol (1998) 1.15
Expression of strain-specific surface antigens on Plasmodium falciparum-infected erythrocytes. Parasite Immunol (1982) 1.14
Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function. J Immunol (1977) 1.14
Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur J Immunol (1998) 1.13
Evolution of a lesser fitness trait: egg production in the specialist Drosophila sechellia. Genet Res (1997) 1.12
Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis. Arthritis Rheum (1980) 1.12
Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. Am J Trop Med Hyg (1995) 1.10
Contrasting patterns of geographic variation in the cosmopolitan sibling species Drosophila melanogaster and Drosophila simulans. Biochem Genet (1987) 1.10
Sequence analysis of active mariner elements in natural populations of Drosophila simulans. Genetics (1992) 1.10
The adherence of human neutrophils and eosinophils to schistosomula: evidence for membrane fusion between cells and parasites. J Cell Biol (1980) 1.10
STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis. Eur J Immunol (1999) 1.08
Pernicous anaemia, hypogammaglobulinaemia, and altered lymphocyte reactivity. A family study. Clin Exp Immunol (1972) 1.08
Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J Immunol (1998) 1.08
Plasminogen activator production by human monocytes. I. Enhancement by activated lymphocytes and lymphocyte products. J Immunol (1979) 1.08
Effect of psychological stress on the induction of arthritis in rats. Arthritis Rheum (1980) 1.08